Identification of Sequential IgE-Binding Epitopes on Bovine αs2-Casein in Cow’s Milk Allergic PatientsBusse P.J. · Järvinen K.M. · Vila L. · Beyer K. · Sampson H.A.
Department of Pediatrics, Division of Allergy and Immunology, and Jaffe Institute for Food Allergy, The Mount Sinai School of Medicine, New York, N.Y., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Caseins are the major allergens responsible for cow’s milk allergy (CMA). We have previously identified the IgE-binding epitopes of the major cow’s milk (CM) proteins except for αs2-casein. Methods: Overlapping decapeptides representing the entire length of αs2-casein were synthesized on a cellulose-derivatized membrane. Sera from 13 CM-allergic children, 4–15 years of age, with a median level of CM-specific IgE >100 kU/l (range 33.7 to > 100 kU/l) were used to identify IgE-binding epitopes. Results: Four major and six minor sequential IgE-binding regions were identified on αs2-casein. The first major region is located in the middle of the protein at amino acids (AA) 83–100, and the other three major regions are located in the carboxy terminal portion of the protein at AA 143–158, 157–172 and 165–188. The minor IgE-binding regions were identified at AA 31–44, 43–56, 93–106, 105–114, 117–128, and 191–200. Conclusion: We identified 10 sequential IgE-binding regions on αs2-casein and performed the first crucial step in the development of immunotherapeutic interventions for CMA.
© 2002 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.